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Abstract 
Background: Preemptive analgesia is considered an alternative for treating the postsurgical pain of third molar 
removal. The aim of this study was to evaluate the preemptive analgesic efficacy of oral ketorolac versus intra-
muscular tramadol after a mandibular third molar surgery. 
Material and Methods: A parallel, double-blind, randomized, placebo-controlled clinical trial was carried out. 
Thirty patients were randomized into two treatment groups using a series of random numbers: Group A, oral 
ketorolac 10 mg plus intramuscular placebo (1 mL saline solution); or Group B, oral placebo (similar tablet to oral 
ketorolac) plus intramuscular tramadol 50 mg diluted in 1 mL saline solution. These treatments were given 30 
min before the surgery. We evaluated the time of first analgesic rescue medication, pain intensity, total analgesic 
consumption and adverse effects. 
Results: Patients taking oral ketorolac had longer time of analgesic covering and less postoperative pain when 
compared with patients receiving intramuscular tramadol. 
Conclusions: According to the VAS and AUC results, this study suggests that 10 mg of oral ketorolac had superior 
analgesic effect than 50 mg of tramadol when administered before a mandibular third molar surgery.
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Introduction
Third molar surgery is the most common procedure 
carried out by oral and maxillofacial surgeons, and it 
is a common model for evaluating the efficacy of anal-
gesics for acute dental pain relief (1). It is often associ-
ated with swelling, pain, and trismus (2). Pain associ-
ated with surgical removal of mandibular third molars 
ranges between moderate and severe during the first 24 
hours (h) after surgery, with the major pain intensity 
occurring between 6 and 8 h when a conventional local 
anesthetic is used (3). 
Preoperative administration of some analgesics has 
demonstrated reducing the onset of postoperative pain 
(1). It has been suggested that preemptive analgesia (an-
algesia given before the painful stimulus begins) is an 
alternative for treating the postsurgical pain of third mo-
lar removal (4). This therapeutic approach prevents or 
reduces the development of any “memory” of the pain 
stimulus in the nervous system. Preemptive analgesia 
may be defined as an antinociceptive treatment that pre-
vents establishment of altered central processing of af-
ferent inputs from injury sites. The most important con-
ditions to achieve an effective preemptive analgesia are 
establish an appropriate blood level of analgesic before 
the surgical injury, and continuation of this effective an-
algesic level into the post-injury period to prevent cen-
tral sensitization during the inflammatory phase (5).
Three classes of analgesic drugs have been used for 
pain control after mandibular third molar surgery: 
Local anesthetics, Non-Steroidal Anti-inflammatory 
Drugs (NSAIDs), and opioids (1,6-10). Ketorolac is an 
NSAID that has showed to be effective after oral and 
parenteral administration. This drug produces its effect 
through inhibiting synthesis of prostaglandins, the fatty 
acid that promotes pain (11-13). Additional mechanisms 
of action have been proposed to explain the efficacy and 
high potency of ketorolac, including a modulator effect 
on opioid receptors (14) and stimulation of nitric oxide 
release (11). Tramadol is an opioid analgesic effective 
in treating moderate to severe pain. It has a low ad-
diction potential. It is used against multiple acute pain 
conditions, including postsurgical pain (15). It acts on 
opioid receptors and seems to modify the transmission 
of pain, inhibiting the reuptake of serotonin and nora-
drenaline (16). The aim of this study was to evaluate the 
preemptive analgesic efficacy of oral ketorolac versus 
intramuscular (IM) tramadol after a mandibular third 
molar surgery.
Material and Methods
This pilot study was a parallel, double-blind, random-
ized, placebo-controlled clinical trial carried out in the 
Department of Oral and Maxillofacial Surgery of the 
Faculty of Dentistry, San Luis Potosi University, Mex-
ico, following the guidelines suggested by the Consoli-
dated Standards of Reporting Trials (CONSORT) group 
for planning and reporting clinical trials (17); conducted 
in accordance with the Declaration of Helsinki, and the 
Ethics Committee approved the study design. All the 
subjects were informed of the possible risks of oral sur-
gery and experimental treatments, and they signed an 
institutionally approved consent form.
Inclusion criteria were age 18 to 25 years, either gen-
der, free of systemic disease, clinical and radiographic 
diagnosis of impacted mandibular third molar, no pain 
associated with the subject third molar up to the day of 
surgery, and grade of surgical difficulty II, III or IV. 
Exclusion criteria were the use of analgesics 24 h before 
the procedure, history of seizure disorder, pregnancy or 
lactation, use of oral contraceptive, and known hyper-
sensitivity to the study medications.
All subjects were informed of the possible risks of oral 
surgery and treatments used. Each patient accepted and 
signed an informed consent form. Patients were as-
signed sequential numbers in order of enrollment, and 
they received their allocated treatment according to a 
computer-generated randomization schedule prepared 
before the start of the study. 
Thirty patients were randomized into two treatment 
groups, each with 15 patients, using a series of random 
numbers: group A, oral ketorolac 10 mg plus IM place-
bo (1 mL saline solution); or group B, oral placebo (pill 
with physical characteristics similar to oral ketorolac) 
plus IM tramadol 50 mg diluted in 1 mL saline solution. 
These treatments were given 30 min before start the 
surgery. We evaluated the time of first analgesic rescue 
medication, pain intensity, and total analgesic consump-
tion. The algorithm of the figure 1 shows the progress of 
subjects through the phases of the trial.
All surgical procedures were carried out in the Depart-
ment of Oral Surgery by the same surgeon, and evalu-
ations were carried out by an independent investigator. 
Anesthesia was by nerve block of the lingual, buccal, 
and inferior alveolar nerves using two 1.8-mL cartridg-
es of 2% lidocaine containing 1:100,000 epinephrine. 
Once anesthesia was obtained, surgery was started. A 
mucoperiosteal flap was prepared by making an inci-
sion distal to the mandibular second molar along the an-
terior edge of the ascending ramus of the mandible (this 
flap was used to close the surgical wound). Suturing 
was done with 4-0 silk, and the number of sutures was 
documented. Mandibular third molars were classified 
according to the Winter Classification, in addition to the 
Pell and Gregory classification. Surgical difficulty was 
based on a modified scale of Parant, as follows: grade I, 
extraction with forceps and elevators; grade II, extrac-
tion by osteotomy; grade III, extraction by osteotomy 
and coronal section; grade IV, extraction by osteotomy, 
root, and coronal section (18). In all cases, duration of 
the operation (from incision to final suture) was record-
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ed. In each patient, a partial bony impacted mandibular 
third molar was extracted.
A 100-mm visual analog scale (VAS) was used to assess 
pain. The VAS consisted of an interval scale ranging 
from 0, representing no pain or discomfort, to 100, rep-
resenting maximum pain or discomfort. The VAS re-
port was recorded each hour for 8 h after completion of 
surgery, and a last evaluation was done at 24 h post-sur-
gery. Patients were given four oral ketorolac 10 mg pills 
and were instructed to take one pill for rescue medica-
tion at least 6 h apart, according to their requirements. 
At the end of the evaluation period (24 h), patients re-
turned the unused oral ketorolac. Pills were counted to 
determine the number of consumed pills and patients in 
each group not needing any pills. Those patients having 
no pain relief 30 min after taking ketorolac were given 
sublingual ketorolac 30 mg as a rescue analgesic proce-
dure. Total analgesic consumption (oral and sublingual 
ketorolac) was evaluated. 
Patients were asked to provide an overall evaluation of the 
analgesic efficacy according to a three-point categorical 
scale, at the end of the trial. The categories of scale were 
1: poor (lots of pain), 2: fair, 3: good (minimum pain). 
Both patients and the independent evaluator were blinded 
regarding the administered treatment. Intra- and postop-
erative complications and adverse events were recorded.
Power analysis of this pilot study was performed using 
the data from the VAS in the third postoperative hour as 
the response variable. The expected difference in means 
was 27.66 mm; while the expected standard deviation 
was 20.95 mm; including 15 patients in each treatment 
group and an alpha value of 0.05. Taking into consider-
ation the data of the response variable, the power of this 
study was 93%.
Data are expressed as mean and standard deviation, me-
dian and ranges or number of frequency and percentage. 
The Fisher exact test was used for to evaluate the sex, 
surgical difficulty, patients without needing analgesic 
during the period of evaluation (8 h) and patients requir-
ing rescue analgesic procedure (sublingual ketorolac). For 
analyze the age, weight, duration of surgery, number of 
suture, total analgesic consumption, and the VAS scores 
the Student t test was utilized. The Mann-Whitney U test 
was used to evaluate the time of first rescue analgesic 
and the overall evaluation of analgesic treatments. The 
area under the curve (AUC) of the VAS was calculated 
using the trapezoidal method and was used to evaluate 
the overall pain intensity. A P value less than 0.05 was 
considered significant statistical difference.
Results
A total of 35 patients were enrolled in the study of 
which 30 patients were included in this clinical trial. 
The statistical analysis was done using the data from 
all included patients (Fig. 1). Personal and surgical 
variables were similar among the groups (Table 1). The 
Fig. 1. Clinical trial flowchart of a subject s´ progress through the phases of the study.
Med Oral Patol Oral Cir Bucal. 2016 Sep 1;21 (5):e637-43.                                                                                                                                                  Analgesic efficacy of ketorolac vs tramadol
e640
time of first rescue analgesic medication was longer in 
the patients taking oral ketorolac when compared with 
patients receiving IM tramadol (P = 0.01). In the same 
way, the patients of group A had less pain when com-
pared with patients of group B, the AUC of VAS showed 
statistical difference (P = 0.04; Fig. 2). However; others 
indicators of analgesic efficacy evaluated through the 
study - patients not needing analgesic during the period 
of evaluation, patients requiring rescue analgesic (sub-
lingual ketorolac 30 mg), and analgesic consumption - 
did not show statistically significant differences among 
the treatment groups (Table 2). 
Patients taking 10 mg of oral ketorolac plus intramus-
cular placebo presented lower pain intensity scores in 
the third and fourth post-operative hour according to 
VAS when compared with patients who receiving oral 
placebo and 50 mg of intramuscular placebo (Table 3). 
Moreover, the distribution of scores of overall evalua-
tion of the analgesic treatments showed more patients 
in the ketorolac group (73.3%) who informing a good 
effect of analgesia when compared with tramadol group 
(26.6%) (P = 0.02; Fig. 3). There were no complications 
associated with the surgical procedure itself. No patient 
reported adverse events.
Variable
Group A
(n=15)
Group B
(n=15) P Value
Age (years) (median and ranges) 21 (18 - 23) 23 (19 - 27) 0.537
Sex (Female:Male) 10:5 9:6 1
Weight (Kg) (median and ranges) 59 (52 - 75) 61 (54 - 65) 0.841
Mesioangular / Horizontal* 11 / 4 9 / 6 0.69
Clase 1† 15 15 1
Position A / B† 3 / 12 5 / 10 0.68
Duration of Operation (mean ± SD)‡ 17.1 ± 2.9 18.7 ± 2.1 0.643
Surgical Difficulty (Grade II / IV)§ 6 / 9 7 / 8 1
Number of sutures (mean ± SD) 3.3 ± 0.8 3.4 ± 0.6 0.781
Table 1. Personal and surgical data.
Group A, oral ketorolac 10 mg plus intramuscular placebo; Group B, oral placebo plus intramus-
cular tramadol 50 mg. *: Winter Classification. †: Pell and Gregory classification. ‡: Surgical dura-
tion of operation in minutes. §: Difficulty: Grade II, extraction by osteotomy; Grade III, extraction 
by osteotomy and coronal section; Grade IV, extraction by osteotomy, root and coronal section.
Fig. 2. Pain intensity evaluated by AUC of VAS. 
Group A, oral ketorolac 10 mg plus intramuscular placebo; Group B, oral placebo plus intramuscular tramadol 
50 mg (P=0.043).
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Discussion
The results of this study shown that patients who took 10 
mg of oral ketorolac had an improved analgesic efficacy 
according to the VAS scores as well as with the AUC of 
VAS, and a longer time of first rescue analgesic medica-
tion than those patients receiving 50 mg of intramuscu-
lar tramadol. Few studies have compared tramadol and 
ketorolac for the pain relief after oral and maxillofacial 
surgery (19-22). Gopalraju et al., (19) compared the in-
travenous analgesia of 30 mg of ketorolac and 50 mg of 
Variable
Group A
(n=15)
Group B
(n=15)
P Value
Time of first rescue analgesic (h) (median and ranges) 4.8 (3.4 - 9.5) 3.1 (3 - 24) 0.015
Patients without needing analgesic during the period of evaluation (24-h) 1 (6.6%) 3 (20%) 0.598
Patients requiring rescue analgesic procedure (sublingual ketorolac) 1 (6.6%) 3 (20%) 0.598
Total analgesic consumption (median and ranges)* 3 (0 - 4) 2 (0 - 3) 0.413
Hour
Visual Analogue Scale (mm)
P ValueGroup A Group B
1 1.25 10.25 0.09
2 7.66 19.75 0.10
3 6.25 33.91 0.008
4 11.58 31.66 0.04
5 16.91 19 0.79
6 8.58 13.08 0.43
7 9.08 16.25 0.28
8 8.16 24.01 0.07
24 0.10 7.34 0.86
Table 2. Comparison of the analgesic efficacy.
Group A, oral ketorolac 10 mg plus intramuscular placebo; Group B, oral placebo plus intramuscular tramadol 50 mg. *Total analgesic 
consumption was quantified as number of tablets.
Table 3. Assessment of pain intensity.
Group A, oral ketorolac 10 mg plus intramuscular placebo; Group B, 
oral placebo plus intramuscular tramadol 50 mg.
Fig. 3. Overall evaluation of analgesic treatments.
Group A, oral ketorolac 10 mg plus intramuscular placebo; Group B, oral placebo plus 
intramuscular tramadol 50 mg (P=0.027).
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tramadol after third molar surgery, proving ketorolac to 
produce better control of pain. Mishra et al., (20) carried 
out a double-blind, randomized, clinical trial evaluating 
the analgesic efficacy of both drug and concluded that 
the postoperative administration of 100 mg of tramadol 
is as effective as 20 mg of ketorolac in the relief of pain. 
Shah et al., (21) and Ong et al., (22) made two separate 
clinical studies to assess the preemptive analgesic ef-
fectiveness of 30 mg of ketorolac and 50 mg of trama-
dol using intramuscular and intravenous administration 
respectively, and informed that ketorolac is better than 
tramadol for management of pain prior to oral surgery. 
Moore et al., (23) executed a clinical trial evaluating 
the analgesia of dexketoprofen-tramadol combination 
in acute dental pain. This study included 2 treatment 
groups with individual tramadol (37.5 and 75 mg), 2 
groups using dexketoprofen trometamol (12.5 and 25 
mg), and an ibuprofen group (400 mg). The results show 
that both dexketoprofen trometamol and ibuprofen pro-
duced a better analgesic effect when compared to tra-
madol after third molar surgery. In addition, the data 
confirms that tramadol has an inferior analgesia in this 
kind of surgical procedure.  
The results of this clinical trial showed that the ketoro-
lac group had a longer period for the consumption of 
the first analgesic tablet after surgery when compared 
to the tramadol group. The data shows that 1 patient 
in the ketorolac group and 3 of the tramadol group did 
not require an analgesic during the period of evaluation. 
The trends of outcomes of this variable are confusing 
in relation to the analgesia observed for ketorolac and 
tramadol in this study, which could be explained by the 
personal variability and the subjectivity of the measure-
ment of this variable by patient demand. The same num-
ber of patients was obtained for whom requiring rescue 
analgesic medication. This is in agreement with other 
variables in this clinical trial. It is important to note that 
these variables evaluating the analgesic efficacy did not 
show statistical difference.
The superior analgesic effectiveness of ketorolac in com-
parison to tramadol could be explained by the pathogen-
esis of dental pain, which is largely inflammatory. The 
evidence-based medicine has shown that NSAIDs are 
the best analgesics for dental pain treatment (4). It is 
possible that higher doses of tramadol have a better an-
algesic effect than ketorolac. However, the incidence of 
side effects, particularly nausea and vomiting, may be 
high. Drowsiness, nausea, and dizziness are the most 
common adverse effects of tramadol (15,16). In a study 
of the effects of tramadol on dentoalveolar surgical pain 
by Collins et al., (24), 39% of patients on high doses of 
tramadol (100 mg 4 times a day orally), 12% on moder-
ate doses (50 mg 4 times a day), and 6% on low doses 
(50 mg twice a day) withdrew from the study owing to 
nausea, vomiting, dizziness, or drowsiness. Interesting-
ly, Pozos-Guillén et al., (25) used high doses of pre- and 
postoperative tramadol (100 mg) but the analgesic effect 
was similar to that of what we found in this study using 
50 mg of tramadol; which indicates a limited analgesic 
effect of tramadol, even while using high doses after 
third molar surgery. Moreover, a systematic review and 
meta-analysis demonstrated that a single dose of trama-
dol has a significantly inferior analgesic effectiveness 
and safety profile than NSAIDs in oral surgery (26).
Effective and safe analgesia is one of the many chal-
lenges in health cares. The preoperative use of ketorolac 
is not very common due to its inhibition of prostaglan-
din I2 and thromboxane A2 synthesis, which may cause 
peri- and post-operative bleeding (27). In this study no 
patients reported bleeding complications. In this sense, 
some clinical studies have used preoperative ketorolac 
by different administration-pathway in oral surgery 
without reporting bleeding complications (24,28,29).
In this clinical trial five patients were excluded. These 
patients did not participate in the study because 2 pa-
tients presented pain associated with the subject third 
molar up to the day of surgery, 2 patients took analge-
sics a day before surgery, and 1 patient was allergic to 
NSAIDs. 
According to the VAS and AUC results, this study sug-
gest that 10 mg of oral ketorolac had better analgesic 
effect than 50 mg of tramadol when administered be-
fore a mandibular third molar surgery. Further studies 
employing a larger sample size are necessary to confirm 
these finding.
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